Related Experiment Video
Updated: Aug 11, 2026
09:50
Real-time Quaking-induced Conversion Assay for Detection of CWD Prions in Fecal Material
Published on: September 29, 2017
Variant Creutzfeldt-Jakob disease
H J T Ward1, M W Head, R G Will
1National Creutzfeldt-Jakob Disease Surveillance Unit, University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU, UK.
Clinics in Laboratory Medicine
|May 8, 2003
Summary
Variant Creutzfeldt-Jakob disease (vCJD) is a new human prion disease transmitted from animals. Research is ongoing to understand transmission, exposure, and potential treatments like quinacrine or chloropromazine.
Area of Science:
- Neuroscience
- Infectious Diseases
- Public Health
Background:
- Variant Creutzfeldt-Jakob disease (vCJD) is a novel human prion disease.
- It is the first documented instance of animal prion diseases transmitting to humans.
- Significant uncertainties surround vCJD, including transmission mechanisms and human exposure levels.
Purpose of the Study:
- To address uncertainties regarding vCJD transmission and its public health implications.
- To explore potential therapeutic avenues for human prion diseases.
- To investigate the mechanism of prion replication for treatment development.
Main Methods:
- Review of existing scientific literature on vCJD and prion diseases.
- Analysis of epidemiological data related to Bovine Spongiform Encephalopathy (BSE) and vCJD.
- Exploration of recent pharmacological studies on potential treatments.
Main Results:
- vCJD represents a zoonotic transmission of prion disease.
- Key uncertainties include interspecies transmission, human exposure to BSE, infectious dose, and future disease burden.
- Recent research suggests quinacrine and chloropromazine as potential treatments for human prion diseases.
Conclusions:
- Further scientific research is crucial to answer outstanding questions about vCJD.
- Understanding prion replication mechanisms may pave the way for effective treatments.
- Quinacrine and chloropromazine show promise as candidate therapies for human prion diseases.
Related Concept Videos
01:25Arboviral Encephalitis
Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
01:27Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...